«PSK Pharma» entered the TOP 15 pharmaceutical companies in the media rating according to «Scan-Interfax»
«PSK Pharma» entered the TOP pharmaceutical companies in the media rating prepared by the analytical agency «Scan-Interfax», along with the largest international and domestic manufacturers of medicines.
«PSK Pharma» is included in the TOP 15 largest pharmaceutical companies in terms of the number of mentions in the media by the end of 2024. The increase in the number of mentions was 57%. Thus, the company rose five positions at once, taking a confident 12th place in the list of industry leaders in this indicator. In the second half of 2024, «PSK Pharma» demonstrated even more impressive results, ranking 8th in terms of the number of mentions in the media. More than half of the publications about the company's activities were published in federal publications, which indicates a high level of interest in the manufacturer's events.
In addition, «PSK Pharma» was among the top ten companies in terms of audience reach, maintaining stable performance at the level of the previous year. This result is noteworthy against the background of the general negative dynamics in the industry, where many leaders of the 2023 rating faced a decrease in media coverage.
The promotion in the rating is primarily due to the number of company events and their level, which reflects the dynamic and successful development. Last year, «PSK Pharma» significantly expanded its portfolio of sought–after drugs – more than 15 products were registered in Russia, including drugs for patients with type 2 diabetes and/or obesity - Sugales, Wesfol, Insudive, Vildagliptin PSK, the first domestic dual bronchodilator Respihale, the only infusion antibiotic with the active ingredient tedizolid, a drug for the treatment of orphan diseases – Gaucher disease and Niemann-Pick disease, new drugs and dosages of existing medicines for patients with HIV.
Proprietary developments were patented, and plans for the development of research and production infrastructure were announced.
Media rating from «Scan-Interfax» is formed based on the analysis of a large amount of data from various sources, including the press, television, radio and Internet resources. This allows us to get an objective picture of the media activity of the country's leading pharmaceutical market players.